CEO, Dr. Jeff Soble joins DAIC to discuss the forecast for telepresence and AI in hospitals. In this interview, he discusses how these technologies allow remote specialists and care team members to “be there, without being there” by creating a live, immersive, and information-rich environment for virtual, multi-disciplinary collaboration. By combining state-of-the-art virtual communication technologies with direct-from-modality image streaming, supervisors and specialized ph

[Chicago, IL January 16,2023] – ASCEND Cardiovascular’s newest technology, Catalyst LIVE, currently implemented at two pioneering hospital sites, has pilots underway since 2022 at Stanford Medicine Children’s Health in California and Cook County Health in Illinois. Catalyst LIVE has prompted the expansion of this innovative technology into additional areas and campuses at these pilot sites giving their teams access to state-of-the-art technology, enabling more patients to ben

Highlights of agreement ASCEND’s IT software is used by 50,000 hospitals, clinics, and caregivers. Initial two-year term for North American markets. Ventripoint will be integrated into ASCEND’s IT for cardiovascular care. Toronto, Ontario – December 12, 2023 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company“), (TSXV: VPT; OTC: VPTDF), now bringing its AI-powered heart-scanning technology to the world’s hospitals, is pleased to announce it has entered into a global

Toronto, Ontario – The Newswire – August 18, 2023 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company“), (TSXV:VPT; OTC:VPTDF) is thrilled to announce that Ventripoint and ASCEND Cardiovascular, LLC have developed a new integrated product. Today’s announcement marks a significant milestone in Ventripoint’s commitment to the collaboration between the two companies. ASCEND fits perfectly into Ventripoint’s roadmap for innovation and is a key step in the company’s miss

Toronto, Ontario – The Newswire – August 10, 2023 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company“), (TSXV:VPT; OTC:VPTDF) is thrilled to announce that Ventripoint and Ascend Cardiovascular, a leading provider of cardiovascular IT solutions, have solidified a strategic collaboration. The two companies have signed a letter of intent to explore joint research and development initiatives, knowledge sharing, and combining efforts to bring innovative AI-based solutio

ASCEND Cardiovascular, a leader in cardiovascular structured reporting and workflow innovation, announces the issuance of a patent by the United States Patent and Trademark Office (USPTO), covering its AI-based solution for Categorical Hanging Image Protocols (CHIP). Using AI-based image analysis and machine learning, CHIP automatically categorizes adult Transthoracic Echo (TTE) images by view/modality. This allows ASCEND’s InView solution to intelligently organize and displa